Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

360.98 -4.68 (-1.28%)
Official Closing Price Updated: 4:10 PM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Stryker Corp

< Previous 1 2 3 4 Next >
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs
Intuitive Surgical (NASDAQ: ISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning 
Via MarketBeat
Exposures COVID-19 Product Safety
Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software
From Stryker
Via Business Wire
Microbot Medical spikes 150% on its Endovascular Surgical Robot
Microbot Medical Inc. (NASDAQ: MBOT) stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERT 
Via MarketBeat
Exposures Product Safety
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Stryker reports first quarter 2023 operating results
From Stryker Corporation
Via GlobeNewswire
Healthcare Innovation Drives Medical Device Makers To New Highs
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base. 
Via MarketBeat
Stryker to announce financial results for its first quarter of fiscal year 2023
From Stryker Corporation
Via GlobeNewswire
Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty
From Stryker
Via Business Wire
Stryker announces Annual Meeting of Shareholders
From Stryker Corporation
Via GlobeNewswire
Are These Medical Device Makers Getting Ready To Rally?
Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors. 
Via MarketBeat
Stryker’s Q Guidance System for cranial applications receives FDA clearance
From Stryker
Via Business Wire
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Stryker reports 2022 operating results and 2023 outlook
From Stryker Corporation
Via GlobeNewswire
Stryker to host conference call on January 31, 2023
From Stryker Corporation
Via GlobeNewswire
We Are the Champions: 3 Dividend Growers Wall Street Loves
A way to gain exposure to dividend growers is to invest in a handful of companies across sectors. These are a few of the names research firms like the most. 
Via MarketBeat
Topics ETFs
Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process
From Stryker
Via Business Wire
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
From Stryker Corporation
Via GlobeNewswire
Intuitive Surgical Stock is Both a Legacy and Next-Gen Play
It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQ: ISRG) is turning 22 years old since its U.S. Food and Drug 
Via MarketBeat
Topics Economy
Exposures COVID-19 Interest Rates Supply Chain
Stryker reports third quarter 2022 operating results
From Stryker Corporation
Via GlobeNewswire
Can Mid-Cap Lantheus Continue its 2022 Outperformance?
Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test. 
Via MarketBeat
Topics ETFs Initial Public Offering
Exposures Securities Market
Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting
From Stryker
Via Business Wire
Stryker Launches Monterey AL Interbody System with New Pre-clinical Data
From Stryker
Via Business Wire
Stryker to host conference call on October 31, 2022
From Stryker Corporation
Via GlobeNewswire
Stryker Launches Q Guidance System with Spine Guidance Software
From Stryker
Via Business Wire
Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting
From Stryker
Via Business Wire
Stryker Launches New Gamma4 Hip Fracture Nailing System
From Stryker
Via Business Wire
Stryker reports second quarter 2022 operating results
From Stryker Corporation
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.